Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. (Q53258671)

12 May 2018

title

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. (English)

1 reference

12 May 2018

main subject

cervix uterine cancer

1 reference

2

1 reference

12 May 2018

June-Key Chung

8

object named as

June-Key Chung

1 reference

12 May 2018

author name string

Hyun Hoon Chung

1

1 reference

12 May 2018

Kyung Hee Han

3

1 reference

12 May 2018

Jae Seon Eo

4

1 reference

12 May 2018

Keon Wook Kang

5

1 reference

12 May 2018

Noh-Hyun Park

6

1 reference

12 May 2018

Yong-Sang Song

7

1 reference

12 May 2018

Soon-Beom Kang

9

1 reference

12 May 2018

language of work or name

English

0 references

publication date

24 November 2010

1 reference

12 May 2018

published in

Gynecologic Oncology

1 reference

12 May 2018

volume

120

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

270-274

1 reference

12 May 2018

Focus on endometrial and cervical cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Current status of cervical cancer and HPV infection in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

The increasing frequency of cervical cancer in Korean women under 35.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Prognostic factors in stage I Carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Prognostic factors for local and distant recurrence in Stage I and II cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Metabolic tumor burden predicts for disease progression and death in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.002

10.1016/J.YGYNO.2010.11.002

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

21109300

1 reference

12 May 2018